Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nanomedicine ; 10(4): 745-54, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24333586

RESUMEN

Neurotensin (NTS)-polyplex is a gene nanocarrier that has potential nanomedicine-based applications for the treatment of Parkinson's disease and cancers of cells expressing NTS receptor type 1. We assessed the acute inflammatory response to NTS-polyplex carrying a reporter gene in BALB/c mice. The intravenous injection of NTS-polyplex caused the specific expression of the reporter gene in gastrointestinal cells. Six hours after an intravenous injection of propidium iodide labeled-NTS-polyplex, fluorescent spots were located in the cells of the organs with a mononuclear phagocyte system, suggesting NTS-polyplex clearance. In contrast to lipopolysaccharide and carbon tetrachloride, NTS-polyplex did not increase the serum levels of tumor necrosis factor alpha, interleukin (IL)-1ß, IL-6, bilirubin, aspartate transaminase, and alanine transaminase. NTS-polyplex increased the levels of serum amyloid A and alkaline phosphatase, but these levels normalized after 24 h. Compared to carrageenan, the local injection of NTS-polyplex did not produce inflammation. Our results support the safety of NTS-polyplex. FROM THE CLINICAL EDITOR: This study focuses on the safety of neurotensin (NTS)-polyplex, a gene nanocarrier that has potential in the treatment of Parkinson's disease and cancers of cells expressing NTS receptor type 1. NTS polyplex demonstrates a better safety profile compared with carrageenan, lipopolysaccharide, and carbon tetrachloride in a murine model.


Asunto(s)
Técnicas de Transferencia de Gen , Terapia Genética/métodos , Nanopartículas , Enfermedad de Parkinson/terapia , Receptores de Neurotensina , Seguridad , Administración Intravenosa , Animales , Ratones , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/metabolismo , Receptores de Neurotensina/biosíntesis
2.
Bioresour Technol ; 101(14): 5539-45, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20231092

RESUMEN

The Cfl xyn11A gene, encoding the endo-1,4-beta-xylanase Cfl Xyn11A from Cellulomonas flavigena, was isolated from a genomic DNA library. The open reading frame of the Cfl xyn11A gene was 999 base pairs long and encoded a polypeptide (Cfl Xyn11A) of 332 amino acids with a calculated molecular mass of 35,110Da. The Cfl xyn11A gene was expressed in Escherichia coli and the recombinant enzyme, with an estimated molecular weight of 31kDa was purified and xylanase activity was measured. Cfl Xyn11A showed optimal activity at pH 6.5 and 55 degrees C. The enzyme demonstrated moderate thermal stability as Cfl Xyn11A maintained 50% of its activity when incubated at 55 degrees C for 1h or at 45 degrees C for 6h. This is the first report describing the cloning, expression and functional characterization of an endo-1,4-beta-xylanase-encoding gene from C. flavigena. Cfl Xyn11A may be suitable for industrial applications in the food and feed industries, or in the pre-treatment of lignocellulosic biomass required to improve the yields of fermentable sugars for bioethanol production.


Asunto(s)
Cellulomonas/genética , Cellulomonas/metabolismo , Endo-1,4-beta Xilanasas/química , Biomasa , Clonación Molecular , ADN/metabolismo , Regulación de la Expresión Génica , Regulación Bacteriana de la Expresión Génica , Biblioteca de Genes , Genoma Bacteriano , Concentración de Iones de Hidrógeno , Microbiología Industrial/métodos , Lignina/química , Plásmidos/metabolismo , Temperatura , Factores de Tiempo
3.
Mol Biol Cell ; 20(18): 4120-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19625451

RESUMEN

Here, we have analyzed the subcellular destiny of newly synthesized tight junction protein zona occludens (ZO)-2. After transfection in sparse cells, 74% of cells exhibit ZO-2 at the nucleus, and after 18 h the value decreases to 17%. The mutation S369A located within the nuclear exportation signal 1 of ZO-2 impairs the nuclear export of the protein. Because Ser369 represents a putative protein kinase C (PKC) phosphorylation site, we tested the effect of PKC inhibition and stimulation on the nuclear export of ZO-2. Our results strongly suggest that the departure of ZO-2 from the nucleus is regulated by phosphorylation at Ser369 by novel PKCepsilon. To test the route taken by ZO-2 from synthesis to the plasma membrane, we devised a novel nuclear microinjection assay in which the nucleus served as a reservoir for anti-ZO-2 antibody. Through this assay, we demonstrate that a significant amount of newly synthesized ZO-2 goes into the nucleus and is later relocated to the plasma membrane. These results constitute novel information for understanding the mechanisms that regulate the intracellular fate of ZO-2.


Asunto(s)
Núcleo Celular/enzimología , Proteínas de la Membrana/metabolismo , Proteína Quinasa C-epsilon/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Animales , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Núcleo Celular/efectos de los fármacos , Perros , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/enzimología , Ácidos Grasos Insaturados/farmacología , Inmunoprecipitación , Proteínas de la Membrana/biosíntesis , Proteínas Mutantes/metabolismo , Fosforilación/efectos de los fármacos , Fosfoserina/metabolismo , Unión Proteica/efectos de los fármacos , Proteína Quinasa C-epsilon/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/farmacología , Factores de Tiempo , Transfección , Proteína de la Zonula Occludens-2
4.
Biotechnol Lett ; 30(4): 681-7, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17985078

RESUMEN

A cellulose-binding protein of 105 kDa (CBP105) from Cellulomonas flavigena was purified and its gene was cloned. CBP105 is a processive endoglucanase with maximum activity on carboxymethyl cellulose (CMC) at pH 7.5 and 60 degrees C. Limited proteolysis suggested that CBP105 is composed of one catalytic domain (CD) and two carbohydrate-binding modules (CBM). The nucleotide sequence of the cbp105 gene (AY729806) indicates that CBP105 is a modular enzyme with a family 9 glycoside hydrolase CD linked to a family 3 CBM, two fibronectin III-like domains and a family 2 CBM. This structural organization may be responsible for CBP105 processive CMC degradation.


Asunto(s)
Proteínas Bacterianas/aislamiento & purificación , Celulasa/aislamiento & purificación , Cellulomonas/enzimología , Celulosa/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Celulasa/genética , Celulasa/metabolismo , Cellulomonas/genética , Electroforesis en Gel de Poliacrilamida , Unión Proteica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA